Investment Details
Investor Type
Private Investment Firm
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Early Stage, Growth, Late Stage, Pre-IPO
Geographical Focus
United States
Industries Focus
- Healthcare
- Life Sciences
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Synthetic Biology
- Health Technology
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2012
Casdin Capital, LLC is a private investment firm specializing in the life sciences and healthcare sectors. The firm focuses on biotechnology, healthcare, life sciences, medical devices, pharmaceuticals, diagnostics, synthetic biology, and health technology industries. Casdin Capital invests across various stages, including early stage, growth, late stage, and pre-IPO companies, primarily within the United States. The firm manages assets ranging from $1 million to $50 million per investment.
Founded in 2012, Casdin Capital is headquartered in New York City. The firm employs a team of 12 financial advisors and oversees approximately $2.6 billion in assets under management across eight accounts. Casdin Capital is registered in California, Massachusetts, New York, and Tennessee.
Casdin Capital is known for its disciplined and principled approach to investing, emphasizing patience, persistence, and strong relationships. The firm conducts in-depth fundamental research and due diligence on its portfolio and potential investments, supporting companies that innovate in areas such as molecular information, diagnostics, therapeutics, and health technology. Through strategic investments and long-term partnerships, Casdin Capital is committed to financing the next generation of life science innovation.
Requirements
- Strong management teams
- Innovative technologies
- Scalable business models
- Clear regulatory pathways
- Potential for significant market impact
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- 23andMe
- 4D Molecular Therapeutics
- 908 Devices
- A2 Biotherapeutics
- Absci
- Adaptive Biotechnologies
Mentioned In
-
$24.95
-
$19.95
-
$14.95
-
$39.95
-
$95.00
-
$99.00
-
$299.00
-
$95.00
Claim this Investor
Are you an official representative of Casdin Capital, LLC?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim